Neoplasm of Uncertain Histogenesis — Trials

Neoplasm of Uncertain Histogenesis — Trials · CancerIndex

Clinical trials

Registered studies

91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 2,513 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07155187	A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer	recruiting	Phase 2 / Phase 3	490	AbbVieINDUSTRY	20	Sep 25, 2026	clinicaltrials
NCT07183189	A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC	active not recruiting	Phase 3	582	Suzhou Suncadia Biopharmaceuticals Co., Ltd.